Pharmafile Logo

EM Imaging appoints new chairman

John Jeans to bring firm to forefront of molecular imaging market

EM Imaging John Jeans

The Board of Edinburgh Molecular Imaging (EM Imaging) has appointed John Jeans as non-executive chairman.

Jeans joins with over 35 years of experience having formerly held leadership positions at Bristol-Myers Squibb, Johnson & Johnson and Amersham.

In 2014, Jeans was appointed by the prime minister as the UK’s government life science champion for medical technology and two years prior was awarded CBE for services to healthcare and science.

He said: “The team at Edinburgh Molecular Imaging have made great progress in establishing a strong portfolio of optical imaging opportunities and it’s a privilege to be joining the company as it enters this exciting period of further development.”

Ian Wilson, CEO of EM Imaging, said: “With his extensive experience in the healthcare and diagnostics sector John is an extremely valuable addition to the company.

“His deep expertise and leadership skills will be central to supporting EM Imaging in bringing its novel optical imaging technology to the forefront of the global molecular imaging market.”

Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust.

Article by Nikhil Patel
7th September 2015
From: Sales
Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links